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FDA209P is one of the standard strains for the species *Staphylococcus aureus* ([@B1]) and has been used in various research fields. It was isolated from a human source prior to the introduction of antibiotics, and thus this strain has never been exposed to man-made antibiotics and challenging environmental conditions. Therefore, it would be appropriate to call the FDA209P a drug-naive classical *S. aureus* strain. FDA209P belongs to the sequence type (ST) 464, and is negative for *mecA*, β-lactamase, and many other antibiotic resistance genes. However, it is positive for the tetracycline resistance gene *tet*38. It is susceptible to almost all the clinically available antibiotics, for which it is widely employed as a reference methicillin-sensitive *S. aureus* (MSSA) strain of antibiotic susceptibility assays. The complete genome sequence of this drug-naive strain will help us understand the genomic evolution and antibiotic adaptations of *S. aureus*.

The genome of strain FDA209P was sequenced using a PacBio RS II sequencer (10-kbp insert library; average read length, 9,159 bp; 88,343 reads; average depth 207) and an Illumina MiSeq platform (250-mer paired-end; 3,138,333 × 2 reads). *De novo* assembly using HGAP3 (PacBio DevNet; Pacific Biosciences) produced two circular contigs composed of a chromosome and a plasmid. In order to correct sequencing errors, we mapped the Illumina reads to the PacBio contigs and built consensus sequences using bwa-0.7.5a and samtools-0.1.19 ([@B2], [@B3]). Gene annotation was performed on the Rapid Annotations using Subsystems Technology (RAST) server ([@B4]) and the KEGG Automatic Annotation Server (KAAS) ([@B5]).

The FDA209P chromosomal and plasmid genomes are 2,775,733 bp (GC content, 32.9%) and 27,490 bp (GC content, 30.7%) in size, respectively. The chromosomal genome possesses 2,571 open reading frames, 6 ribosomal operons, and 57 tRNAs. There are 31 protein-coding sequences on the plasmid.

This entry of GenBank on the strain of *S. aureus* FDA209P will contribute to various research fields, such as physiology, evolution, epidemiology, and antimicrobial resistance and tolerance in *S. aureus*.

Nucleotide sequence accession numbers. {#s1}
--------------------------------------

The complete genome sequence of *S. aureus* strain FDA209P has been deposited in GenBank under the accession numbers [AP014942](AP014942) and [AP014943](AP014943) for the chromosome and plasmid, respectively.
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